rent stents are not ideally developed for the venous system (9) . In the last years, an impressive increase in the number of complications of these procedures have been reported. We have reviewed the current literature and counted 816 cases of NCS reported. Of those, 354 were managed clinically (43%); 160 were managed through open, laparoscopic or robotic surgery (20%); and there are 224 reports of endovascular management of NCS (27%). From 2000 to 2005, 12 cases of stent placement for NCS were reported; from 2006 to 2010, 23 cases; and from 2011 to 2016, 189 cases have been reported. But impressively, there were also 21 reports of these venous stents used to treat NCS that have migrated, either immediately after placement or up to 12 months after surgery. Of the total of patients with NCS treated with stents reported in the literature, stent migration occurred in 9% of the cases. Stent migration is relatively common after endovascular stenting. In one of the largest series of endovascular stents, 75 young patients received venous stents for this benign condition. After a short term follow-up, stent migrated in five cases (7%). And unfortunately, there were not any anatomic or stent related factor that could predict this severe complication.
The authors of this study have concluded that venous stent migration in patients with NCS is much more common than believed (11) . In other small series, migration occurred in 17%-20% of cases (8, 12) . And almost all of these cases, migration occurred to the vena cava or to the heart, in many cases with serious complications requiring open heart surgery and even valvar replacement (11, 13, 14) .
Moreover, long term venous stents patency is uncertain with stents. For this reason, experts in the field strongly recommend the maintenance of antiplatelet agents or anticoagulation following endovascular treatment of Nutcracker syndrome (15) . But considering that we are treating young patients, mainly women with 20-40 years, future pregnancies can become risky (16) and lifetime anticoagulation can bring additional concerns.
It is very important to stress some points. Nutcracker syndrome is not always an easy diagnosis. Most patients should be treated conservatively because spontaneous remission does occur. It has been observed that 75% of patients younger than 18 years old will have complete resolution of hematuria within two years of presentation (4) . Similarly, asymptomatic patients with incidental findings of Nutcracker phenomenom should be managed conservatively, as the natural history of such findings is not well delineated (1) . Intervention shall only be indicated in severe lesions when there are disabling symptoms that do not respond to conservative management. When treatment is to be considered, care should be taken, and the best technique should be discussed with the patient or his/her parents. And venous stents don't seem to be a good alternative for this young population of patients with this generally benign disease. We have to take care about whose nuts are we cracking and how we are cracking those nuts. 
